This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMRI Albany Molecular Research (AMRI) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About Albany Molecular Research Stock (NASDAQ:AMRI) 30 days 90 days 365 days Advanced Chart Get AMRI alerts:Sign Up Key Stats Today's Range$21.74▼$21.7450-Day Range$21.74▼$21.7452-Week Range$13.01▼$22.17VolumeN/AAverage Volume872,120 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. The API segment includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates. The DP segment includes pre-formulation, formulation and process development through commercial scale production of complex liquid-filled and lyophilized sterile injectable products and ophthalmic formulations. The FC segment includes lab to commercial scale synthesis of reagents and diverse compounds. It supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of API and drug product for new and generic drugs. Read More Receive AMRI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Albany Molecular Research and its competitors with MarketBeat's FREE daily newsletter. Email Address AMRI Stock News HeadlinesHealthcare Contract Development and Manufacturing Organization (CDMO) Strategic Business Research Report 2023-2030October 16, 2024 | uk.finance.yahoo.comFDA Grants Fast Track Designation For Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD)October 9, 2024 | finance.yahoo.comThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.July 4 at 2:00 AM | Brownstone Research (Ad)Curia Unveils Brand Refresh at CPHI WW in MilanOctober 8, 2024 | finance.yahoo.com$6.1 Bn Vaccine Contract Manufacturing Market by Vaccine Type, Workflow, Application, and Region 2024-2032September 5, 2024 | finance.yahoo.comCatholic representative body is ‘deeply sorry’ for abuse in religious schoolsSeptember 3, 2024 | msn.comDrug Discovery Services Market Forecast to 2030: Discover the Leading Strategic and Regional Growth Trends Major Players are Capitalizing OnAugust 30, 2024 | uk.finance.yahoo.comGlobal Drug Discovery Outsourcing Services Market Size To Exceed USD 7.9 Billion By 2033 | CAGR Of 7.59%August 25, 2024 | finance.yahoo.comSee More Headlines AMRI Stock Analysis - Frequently Asked Questions How were Albany Molecular Research's earnings last quarter? Albany Molecular Research Inc (NASDAQ:AMRI) announced its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.21 by $0.14. The biotechnology company earned $102.80 million during the quarter, compared to analysts' expectations of $107.20 million. What other stocks do shareholders of Albany Molecular Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that Albany Molecular Research investors own include Casella Waste Systems (CWST), Bristol Myers Squibb (BMY), Zevra Therapeutics (KMPH), Teva Pharmaceutical Industries (TEVA), Allergan (AGN), Alpha Lithium (APHLF) and Denison Mine (DNN). Company Calendar Last Earnings5/10/2016Today7/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:AMRI CIK1065087 Webwww.amriglobal.com Phone+1-518-4640279FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:AMRI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Albany Molecular Research Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Albany Molecular Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.